Curis (CRIS) Assets (2010 - 2026)
Curis' (CRIS) quarterly Assets came in at $29.7 million in Q1 2026, down 24.51% YoY from $39.3 million in Q1 2025, and up 48.68% on a QoQ basis from $20.0 million in Q4 2025.
Curis (CRIS) Assets (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Assets data on file, last reported at $29.7 million in Q1 2026.
- Quarterly Assets fell 24.51% year-over-year to $29.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.7 million (down 24.51% YoY) and the FY2025 annual result came in at $20.0 million, down 51.62% from the prior year.
- Assets improved to $29.7 million in Q1 2026, from $20.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $140.7 million in Q1 2022 to a low of $20.0 million in Q4 2025.
- A 5-year average of $70.0 million and a median of $62.0 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets tumbled 52.79% — and 2026, when it slipped 24.51%.
- Tracing CRIS's Assets over 5 years: stood at $108.8 million in 2022, then retreated by 29.0% to $77.3 million in 2023, then slumped by 46.6% to $41.3 million in 2024, then slumped by 51.62% to $20.0 million in 2025, then soared by 48.68% to $29.7 million in 2026.
- The last three Assets figures came in at $29.7 million (Q1 2026), $20.0 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | 18.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.69 Mn |
| Dec 31, 2025 | 19.97 Mn |
| Sep 30, 2025 | 27.64 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Mar 31, 2025 | 39.33 Mn |
| Dec 31, 2024 | 41.27 Mn |
| Sep 30, 2024 | 42.47 Mn |
| Jun 30, 2024 | 50.41 Mn |
| Mar 31, 2024 | 62.02 Mn |
| Dec 31, 2023 | 77.28 Mn |
| Sep 30, 2023 | 89.98 Mn |
| Jun 30, 2023 | 84.31 Mn |
| Mar 31, 2023 | 94.54 Mn |
| Dec 31, 2022 | 108.85 Mn |
| Sep 30, 2022 | 122.85 Mn |
| Jun 30, 2022 | 128.83 Mn |
| Mar 31, 2022 | 140.74 Mn |
| Dec 31, 2021 | 162.30 Mn |
| Sep 30, 2021 | 172.09 Mn |
| Jun 30, 2021 | 181.19 Mn |